Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
FDA Clears Cytrellis' ellacor® Micro-Coring® Technology for Full-Body Resurfacing, expanding applications to treat sagging skin beyond the face.
-
Cytrellis Biosystems' leadership team will support the accelerated commercialization of ellacor platform and expand Cytrellis' market presence.
-
Cytrellis Biosystems has received approval to commercialize its groundbreaking ellacor® with Micro-Coring® technology in Canada and Saudi Arabia.
-
Cytrellis' next-generation ellacor® system with Micro-Coring® enhances patient and provider experience. It will be showcased at industry conferences.
-
Cytrellis marks new era of growth with the launch of ellacor 2.0, fueled by the completion of new financing and theappointment of Dr. Denise Dajles as CEO.